The functional role of two different DNA modifications in glioblastoma (GBM) cancer tissues was explained by a new research, being associated with patient survival. The research was conducted at Dartmouth’s Norris Cotton Cancer Center (NCCC), and was published, Nov. 25, in the journal Nature.